June 18, 2024

Bionpa

You are Your Only Limit

Savant Capital LLC Cuts Position in iShares Biotechnology ETF (NASDAQ:IBB)

3 min read


Savant Capital LLC reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 15.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,707 shares of the financial services provider’s stock after selling 674 shares during the quarter. Savant Capital LLC’s holdings in iShares Biotechnology ETF were worth $504,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in IBB. Glass Jacobson Investment Advisors llc boosted its position in iShares Biotechnology ETF by 150.6% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares during the last quarter. Values First Advisors Inc. purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at about $43,000. Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $44,000. Column Capital Advisors LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth approximately $49,000. Finally, Massmutual Trust Co. FSB ADV raised its position in shares of iShares Biotechnology ETF by 164.2% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 225 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.8 %

iShares Biotechnology ETF stock opened at $132.96 on Monday. The stock has a 50 day moving average of $133.61 and a 200-day moving average of $130.12. The stock has a market cap of $7.27 billion, a P/E ratio of 17.35 and a beta of 0.86. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a $0.126 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)



Receive News & Ratings for iShares Biotechnology ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares Biotechnology ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

bionpa.com All rights reserved. | Newsphere by AF themes.